cerebral palsy Clinical Trials and Research
Also known as: cp, spastic paralysis, infantile cerebral paralysis, brain injury motor disorder, non-progressive motor impairment · ICD-10: G80
Cerebral palsy is a group of conditions affecting movement and posture due to brain damage, often occurring before or around birth. Clinical trial research focuses on improving motor function, managing symptoms, and exploring new therapies. Find a Trial helps patients search for active studies.
Search cerebral palsy trials →
Common questions about cerebral palsy clinical trials
What types of clinical trials are currently active for cerebral palsy?
Active trials for cerebral palsy often investigate new therapies to improve motor skills, reduce spasticity, and manage associated symptoms like pain or communication difficulties. Researchers are exploring rehabilitation techniques, medications, and cell-based therapies, according to data from ClinicalTrials.gov.
Who is eligible to participate in cerebral palsy clinical trials?
Eligibility criteria vary significantly by study, often depending on factors like age, specific type of cerebral palsy, symptom severity, and overall health. Each trial has unique requirements designed to ensure patient safety and study relevance, as detailed on ClinicalTrials.gov.
What are common interventions being studied in cerebral palsy trials?
Common interventions include various forms of physical and occupational therapy, medication for spasticity, surgical procedures, and assistive devices. Emerging areas involve stem cell therapies and neurorehabilitation technologies, as seen in research listed on ClinicalTrials.gov and NIH RePORTER.
Do clinical trials for cerebral palsy cost money to participate in?
Generally, study-related medical care and interventions in clinical trials are provided at no cost to participants. However, patients might be responsible for travel, lodging, or non-study related medical expenses. This information is always clearly outlined by the research team.
What are the different phases of clinical trials for cerebral palsy?
Clinical trials progress through phases: Phase 1 tests safety, Phase 2 evaluates effectiveness and side effects, and Phase 3 compares new treatments to existing ones. Phase 4 studies long-term effects after approval. This structured approach ensures thorough evaluation of new interventions.
What are researchers learning about the causes of cerebral palsy?
Researchers are continually investigating the complex causes of cerebral palsy, including genetic factors, infections during pregnancy, and complications during birth. Studies aim to identify risk factors and potential preventative strategies, as evidenced by research on NIH RePORTER.
Are there specific biomarkers or diagnostic tools being studied for cerebral palsy?
Research is ongoing into potential biomarkers and advanced imaging techniques to improve early diagnosis and predict outcomes in cerebral palsy. These studies aim to identify indicators that could help tailor interventions more effectively, according to NIH RePORTER data.
What are some common reasons a patient might be excluded from a cerebral palsy trial?
Common exclusion criteria can include co-existing medical conditions, use of certain medications that might interfere with the study, or a history of specific surgeries. These criteria help ensure participant safety and the integrity of the research findings, as specified in trial protocols.
How to find a cerebral palsy trial that fits you
- Describe your cerebral palsy situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all cerebral palsy trials →